Anshul Maheshwari, Chief Operating and Financial Officer of SI-BONE, Inc. (NASDAQ:SIBN), filed a Form 4 on November 2, 2026, disclosing the sale of 3,738 shares of common stock on October 29, 2026.

Key Highlights

  • Transaction: Anshul Maheshwari disposed of 3,738 shares of SI-BONE common stock on October 29, 2026.
  • Sale price: Shares were sold at $22.50 each, according to the filing.
  • Post-transaction ownership: Maheshwari beneficially owned 214,497 shares following the reported transaction.
  • RSU component: The post-transaction total includes 160,823 shares issuable on settlement of restricted stock units, each representing a contingent right to receive one share of common stock.
  • 10b5-1 plan: The sale was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.
  • Reporting person role: Maheshwari is identified in the filing as Chief Operating and Financial Officer of SI-BONE, Inc.

SI-BONE Chief Operating and Financial Officer Discloses October 2026 Share Sale

According to the Form 4 filed with the SEC on November 2, 2026, Anshul Maheshwari, Chief Operating and Financial Officer of SI-BONE, Inc. (NASDAQ:SIBN), sold 3,738 shares of the company's common stock on October 29, 2026, at a price of $22.50 per share. The transaction is coded "S" in the filing, indicating a sale of directly held securities.

The filing states that the sale was made pursuant to a Rule 10b5-1 trading plan established on December 17, 2025. Following the transaction, Maheshwari's reported beneficial ownership stands at 214,497 shares held directly. The filing notes that this figure includes 160,823 shares issuable upon settlement of restricted stock units previously granted to the reporting person, with each restricted stock unit representing a contingent right to receive one share of the issuer's common stock.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Michael Pisetsky as Attorney-in-Fact for Anshul Maheshwari and dated November 2, 2026. The filing indicates it was made by one reporting person and is not an amendment to a prior filing.

What Was Disclosed

The filing disclosed a single sale of 3,738 shares of SI-BONE common stock by its Chief Operating and Financial Officer on October 29, 2026, at $22.50 per share under a pre-established 10b5-1 plan, with 214,497 shares beneficially owned afterward.